Prevalence of polypharmacy and associated adverse health outcomes in adult patients with chronic kidney disease: protocol for a systematic review and meta-analysis

BACKGROUND: Polypharmacy, often defined as the concomitant use of ≥ 5 medications, has been identified as a significant global public health threat. Aging and multimorbidity are key drivers of polypharmacy and have been linked to a broad range of adverse health outcomes and mortality. Patients with...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Syst Rev
Asıl Yazarlar: Okpechi, Ikechi G., Tinwala, Mohammed M., Muneer, Shezel, Zaidi, Deenaz, Ye, Feng, Hamonic, Laura N., Khan, Maryam, Sultana, Naima, Brimble, Scott, Grill, Allan, Klarenbach, Scott, Lindeman, Cliff, Molnar, Amber, Nitsch, Dorothea, Ronksley, Paul, Shojai, Soroush, Soos, Boglarka, Tangri, Navdeep, Thompson, Stephanie, Tuot, Delphine, Drummond, Neil, Mangin, Dee, Bello, Aminu K.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2021
Konular:
Protocol
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8256607/
https://ncbi.nlm.nih.gov/pubmed/34218816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13643-021-01752-z
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller